4th Quarter - Report

CENCORA, INC. for CENCORA, INC.

Firm
Client
Income
—
Expenses
$1,910,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R.4299) Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages CMS Proposed Medicare Physician Fee Schedule Rule Proposed Changes to Bonafide Service Fees

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
SHELLY MUI-LIPNIK —
DARRELL ROGERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 2426 (119th), H.R. 3164 (119th), H.R. 4299 (119th)

Pharmacy PHA

Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426)- Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA)

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
SHELLY MUI-LIPNIK —
DARRELL ROGERS —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; White House Office

Bills named: H.R. 3164 (119th), S. 2426 (119th)

Health Issues HCR

Strategic National Stockpile Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pharmaceutical supply chain resilience Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R. 2483/S.2121) Medical Supply Resiliency Act (H.R. 2231) National Defense Authorization Act FY2026 (NDAA) Supply Chain Resiliency Most Favored Nation drug pricing proposals CMS Proposed Medicare Physician Fee Schedule Rule

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
SHELLY MUI-LIPNIK —
DARRELL ROGERS —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); White House Office; SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2027 (119th), H.R. 2483 (119th), H.R. 4132 (119th), S. 2121 (119th), H.R. 2231 (119th)

Taxation/Internal Revenue Code TAX

Global Intangible Low-taxed Income (GILTI) Last in First Out (LIFO) accounting method

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
SHELLY MUI-LIPNIK —
DARRELL ROGERS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Tariff proposed policies

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
SHELLY MUI-LIPNIK —
DARRELL ROGERS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.